Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes

Clinical and Experimental Immunology

Volumn 180, Issue 2, 2015, Pages 207-217

  Gomez Tourino I ^a,g   Simon Vazquez R ^d   Alonso Lorenzo, J ^b,h   Arif, S ^g   Calvino Sampedro C ^a   Gonzalez Fernandez A ^d   Pena Gonzalez E ^e   Rodriguez J ^c   Vinuela Roldan J ^c   Verdaguer, J ^f   Cordero, O J ^a   Peakman, M ^g   Varela Calvino, R ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Santiago University Clinical Hospital   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d UNIVERSITY OF VIGO   (Spain)

^e HOSPITAL DO MEIXOEIRO   (Spain)

^f UNIVERSITY OF LLEIDA   (Spain)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Autoimmunity; Peptide epitopes; S100 ; Th1; Type 1 diabetes

Indexed keywords

GAMMA INTERFERON; HLA DRB1 ANTIGEN; INTERLEUKIN 10; PROTEIN S100B; AUTOANTIGEN; EPITOPE; HLA-DRB1*04:01 ANTIGEN; IFNG PROTEIN, HUMAN; S100B PROTEIN, HUMAN;

ADULT; AMINO ACID SEQUENCE; AREA UNDER THE CURVE; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE DURATION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; NERVOUS TISSUE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; YOUNG ADULT; FEMALE; GENETICS; IMMUNOLOGY; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY;

AUTOANTIGENS; BASE SEQUENCE; DIABETES MELLITUS, TYPE 1; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-DRB1 CHAINS; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MALE; MOLECULAR SEQUENCE DATA; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; T-LYMPHOCYTES;

EID: 84927589383     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12572     Document Type: Article

References (34)

1. Babad J, Geliebter A, DiLorenzo TP. T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes. Immunology 2010; 131:459-465.
2. Roep BO, Peakman M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med 2012; 2:a007781.
3. Chaparro RJ, Dilorenzo TP. An update on the use of NOD mice to study autoimmune (Type 1) diabetes. Expert Rev Clin Immunol 2010; 6:939-955.
4. Coppieters KT, Dotta F, Amirian N etal. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 2012; 209:51-60.
5. Winer S, Tsui H, Lau A etal. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med 2003; 9:198-205.
6. Gomez-Tourino I, Camina-Darriba F, Otero-Romero I etal. Autoantibodies to glial fibrillary acid protein and S100beta in diabetic patients. Diabet Med 2010; 27:246-248.
7. Burbelo PD, Lebovitz EE, Bren KE etal. Extrapancreatic autoantibody profiles in type I diabetes. PLOS ONE 2012; 7:e45216.
8. Banwell B, Bar-Or A, Cheung R etal. Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes. Ann Neurol 2008; 63:98-111.
9. Tsui H, Chan Y, Tang L etal. Targeting of pancreatic glia in type 1 diabetes. Diabetes 2008; 57:918-928.
10. Standifer NE, Ouyang Q, Panagiotopoulos C etal. Identification of novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes 2006; 55:3061-3067.
11. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004; 322:1111-1122.
12. Kojima K, Berger T, Lassmann H etal. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med 1994; 180:817-829.
13. Schmidt S, Linington C, Zipp F etal. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Brain 1997; 120:1437-1445.
14. Bunce M. PCR-sequence-specific primer typing of HLA class I and class II alleles. Methods Mol Biol 2003; 210:143-171.
15. Peakman M, Stevens EJ, Lohmann T etal. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest 1999; 104:1449-1457.
16. Arif S, Tree TI, Astill TP etal. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004; 113:451-463.
17. Arif S, Moore F, Marks K etal. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated {beta}-cell death. Diabetes 2011; 60:2112-2119.
18. Herold KC, Brooks-Worrell B, Palmer J etal. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes 2009; 58:2588-2595.
19. Stevens EJ, Peakman M. Enhanced T cell proliferation and increased responder frequency following delivery of antigen to the antigen-presenting cell; B cell dependency and use in detection of autoreactive T cells. J Immunol Methods 1998; 215:59-70.
20. O'Brien C, Flower DR, Feighery C. Peptide length significantly influences in vitro affinity for MHC class II molecules. Immunome Res 2008; 4:6.
21. Gebe JA, Falk BA, Rock KA etal. Low-avidity recognition by CD4+ T cells directed to self-antigens. Eur J Immunol 2003; 33:1409-1417.
22. Danke NA, Yang J, Greenbaum C, Kwok WW. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects. J Autoimmun 2005; 25:303-311.
23. Yang J, Danke NA, Berger D etal. Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J Immunol 2006; 176:2781-2789.
24. Dang M, Rockell J, Wagner R etal. Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol 2011; 186:6056-6063.
25. Viglietta V, Kent SC, Orban T, Hafler DA. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest 2002; 109:895-903.
26. Toma A, Haddouk S, Briand JP etal. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci USA 2005; 102:10581-10586.
27. Toma A, Laika T, Haddouk S etal. Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes. Diabetes 2009; 58:394-402.
28. Laughlin E, Burke G, Pugliese A, Falk B, Nepom G. Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation. Clin Immunol 2008; 128:23-30.
29. Vendrame F, Pileggi A, Laughlin E etal. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 2010; 59:947-957.
30. Steiner J, Bernstein HG, Bielau H etal. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci 2007; 8:2.
31. Yamashita M, Qian ZR, Sano T, Horvath E, Kovacs K. Immunohistochemical study on so-called follicular cells and folliculostellate cells in the human adenohypophysis. Pathol Int 2005; 55:244-247.
32. Donato R, Sorci G, Riuzzi F etal. S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 2009; 1793:1008-1022.
33. Steiner J, Bernstein HG, Schiltz K etal. Decrease of serum S100B during an oral glucose tolerance test correlates inversely with the insulin response. Psychoneuroendocrinology 2014; 39:33-38.
34. Kaufman DL, Clare-Salzler M, Tian J etal. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366:69-72.